LexDanaLexDanabeta
Inventor

Anthony Kreft

Inventor
Langhorne, PA, US

Overview

63→
Patents
1984–2011
Patent span
Chemistry
Primary field (CPC C)

Patents· 63 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
A61KPreparations for medical, dental or toiletry purposes14%
C07CAcyclic or carbocyclic compounds11%
C07KPeptides7%
Y02ATechnologies for adaptation to climate change5%
C07BGeneral methods of organic chemistry2%
PatentTitleYear
7,973,044'Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4'20117,968,547'Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4'20117,858,658'Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof'20107,842,718'Heterocyclic sulfonamide inhibitors of beta amyloid production'20107,745,454'Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4'20107,691,884'Heterocyclic sulfonamide inhibitors of β amyloid production'20107,674,813'Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole'20107,671,075'Substituted phenylsulfonamide inhibitors of beta amyloid production'20107,550,629'Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors'20097,547,725'Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof'20097,399,778'Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole'20087,378,529'Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4'20087,320,960'Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4'20087,300,951'Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof'20077,291,645'Phenylalanine derivatives as alpha 4 integrin inhibitors'20077,229,970'Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4'20077,223,762'Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4'20077,166,622'Substituted phenylsulfonamide inhibitors of beta amyloid production'20077,101,855'Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4'20067,015,216'Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors'20066,953,802'Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4'20056,911,439'Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4'20056,900,179'Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4'20056,878,742'Heterocyclic sulfonamide inhibitors of beta amyloid production'20056,803,370'Alpha amino acid derivativesinhibitors of leukocyte adhesion mediated by VLA-4'20046,800,764'Process for the synthesis of chirally pure beta-amino-alcohols'20046,794,506'3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4'20046,689,781'Phenylalanine derivatives as alpha 4 integrin inhibitors'20046,610,734'Heterocyclic sulfonamide inhibitors of beta amyloid production'20036,583,139'Compounds which inhibit leukocyte adhesion mediated by VLA-4'20036,525,026'Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4'20036,492,372'Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4'20026,492,421'Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4'20026,489,300'Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4'20026,479,492'Compounds which inhibit leukocyte adhesion mediated by VLA-4'20026,407,066'Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4'20026,291,453'4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4'20015,830,911'Pyranoindole and tetrahydrocarbazole inhibitors of COX-2'19985,824,699'Carbazole inhibitors of Cox-2'19985,776,967'Pyranoindole inhibitors of COX--2'19985,420,289'Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA.sub.2 and lipoxygenase'19955,364,944'Substituted benzoylbenzene-, biphenyl- and 2-oxazole- alkanoic acid compounds'19945,250,693'Quinolinylmethoxy naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents'19935,229,516'Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase'19935,218,124'Substituted benzoylbenzene-, biphenyl- and 2-oxazole-alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase'19935,208,344'Naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents'19935,159,085'2-anilino phenylacetic acid derivatives as inhibitors of PLA.sub.2 and lipoxygenase'19925,103,014'Certain 3,3\'-[[[(2-phenyl-4-thiazolyl)methoxy]phenyl]methylene]dithiobis-propano ic acid derivatives'19925,071,988'Substituted benzoylbenzene-, biphenyl- and 2-oxazole-alkanoic acid derivatives'19915,021,576'2-Anilino phenylacetic acid derivatives'19914,960,892'Naphthalenepropionic acid derivatives as anti-inflammatory/anti-allergic agents'19904,942,236'2-aryl substituted pyridyl-containing phenyl sulfonamido compounds as antiallergic and antiinflammatory agents'19904,904,786'Quinoline compounds as antiallergic and antiinflammatory agents'19904,895,953'2-Aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents'19904,876,346'Quinoline compounds'19894,826,990'2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents'19894,772,703'2-(phenoxymethyl)-quinazolines as antiallergic and antiinflammatory agents'19884,754,043'Oxazole and thiazole naphthalenes as antiallergic agents'19884,719,308'Imidazolylmethoxy naphthalene compounds as antiallergic agents'19884,675,405'Quinoline compounds as antiallergic and antithrombotic agents'19874,661,596'Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents'19874,642,347'3(2-quinolinylalkoxy)phenols'19874,448,729'Leucotriene antagonists'1984

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1984–2004Patents assigned to AMERICAN HOME PROD (32)· patent assignee history
1984–1988Based in Devon, PA, US· patent location history
1988–1992Based in Trooper, PA, US· patent location history
1991–2011Based in Langhorne, PA, US· patent location history
2001–2002Patents assigned to ATHENA NEUROSCIENCES INC (2)· patent assignee history
2002–2011Patents assigned to ELAN PHARM INC (12)· patent assignee history
2003–2011Patents assigned to WYETH CORP (24)· patent assignee history
2003–2010Patents assigned to ARQULE INC (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AMERICAN HOME PROD321984–2004
WYETH CORP242003–2011
ELAN PHARM INC122002–2011
ARQULE INC62003–2010
ATHENA NEUROSCIENCES INC22001–2002
Locations
LocationPatentsSpan
Langhorne, Pennsylvania, US481991–2011
Trooper, Pennsylvania, US91988–1992
Devon, Pennsylvania, US61984–1988